Altimmune Inc (ALT)
6.74
0.00 (0.00%)
USD |
NASDAQ |
Nov 01, 16:00
6.70
-0.04
(-0.59%)
After-Hours: 20:00
Altimmune Price to Book Value: 3.140 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 3.140 |
| October 31, 2024 | 3.140 |
| October 30, 2024 | 3.150 |
| October 29, 2024 | 3.429 |
| October 28, 2024 | 3.266 |
| October 25, 2024 | 3.117 |
| October 24, 2024 | 3.152 |
| October 23, 2024 | 3.131 |
| October 22, 2024 | 3.168 |
| October 21, 2024 | 3.215 |
| October 18, 2024 | 3.206 |
| October 17, 2024 | 3.164 |
| October 16, 2024 | 3.196 |
| October 15, 2024 | 3.280 |
| October 14, 2024 | 2.996 |
| October 11, 2024 | 2.936 |
| October 10, 2024 | 2.805 |
| October 09, 2024 | 2.847 |
| October 08, 2024 | 2.908 |
| October 07, 2024 | 2.842 |
| October 04, 2024 | 2.903 |
| October 03, 2024 | 2.866 |
| October 02, 2024 | 2.922 |
| October 01, 2024 | 2.931 |
| September 30, 2024 | 2.861 |
| Date | Value |
|---|---|
| September 27, 2024 | 3.015 |
| September 26, 2024 | 3.173 |
| September 25, 2024 | 3.262 |
| September 24, 2024 | 3.318 |
| September 23, 2024 | 3.355 |
| September 20, 2024 | 3.630 |
| September 19, 2024 | 3.527 |
| September 18, 2024 | 3.462 |
| September 17, 2024 | 3.527 |
| September 16, 2024 | 3.532 |
| September 13, 2024 | 3.672 |
| September 12, 2024 | 3.308 |
| September 11, 2024 | 3.341 |
| September 10, 2024 | 3.243 |
| September 09, 2024 | 2.973 |
| September 06, 2024 | 2.889 |
| September 05, 2024 | 2.977 |
| September 04, 2024 | 3.029 |
| September 03, 2024 | 2.973 |
| August 30, 2024 | 3.122 |
| August 29, 2024 | 3.080 |
| August 28, 2024 | 3.019 |
| August 27, 2024 | 3.122 |
| August 26, 2024 | 3.196 |
| August 23, 2024 | 3.234 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4752
Minimum
Nov 19 2019
13.39
Maximum
Jul 20 2020
2.478
Average
2.173
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 54.59 |
| Viking Therapeutics Inc | 8.910 |
| Amgen Inc | 22.80 |
| Avid Bioservices Inc | 11.17 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 1045.85 |
| PEG Ratio | -6.699 |
| Price | 6.74 |
| Earnings Yield | -24.33% |
| Market Cap | 479.02M |